Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Cornfeld, MD, MPH
Idera Pharmaceuticals, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Centers of Excellence
Fayetteville, Arkansas, United States
- Ucla
Los Angeles, California, United States
- Mayo Clinic Jacksonville
Jacksonville, Florida, United States
- Emory Winship Cancer Institute
Atlanta, Georgia, United States
- Horizon Bioadvance
Lafayette, Indiana, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Hackensack University
Hackensack, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2014
- Primary completion
- 30 Apr 2017
- Completion
- 30 Nov 2017
- Last update posted
- 10 Sept 2019
- Registered enrollment
- 31
- Registry id
- NCT02092909
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.